Skip to content

effect of intervenous administration of dexametason and fentanil on reduction of propofol induced pain during intravenous injection

comparision of effect of intervenous administration of dexametason with fentanil on reduction of propofol induced pain during intravenous injection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015021015281N2
Enrollment
150
Registered
2015-11-04
Start date
2015-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications of anaesthesia. Other complications of anaesthesia

Interventions

Intervention 1: Control group: first group, 5 cc normal salin 0.9 , 1 min before propofol injection. Intervention 2: Interventional group: second group, 8 mg dexametason, 5 cc , 1 min before propofol
Treatment - Drugs
Interventional group: second group, 8 mg dexametason, 5 cc , 1 min before propofol injection
Interventional group: thirth group,100 micro gram fantanil, 5 cc , 1 min before propofol injection

Sponsors

International Branch,Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients of 16 to 60 y/o admitted for general surgery Exclusion criteria: the patients who received sedative drugs 48hr before operation; have drug allergy; with neurological disorders or mental,drug Addicts; Pregnant women and who require a rapid induction of anesthesia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Effect of fentanil on reduction of propofol induced pain during intravenousinjection. Timepoint: 1 minute after injection of propofol. Method of measurement: Fill questionare and visual scale.;Effect of dexametason on reduction of propofol induced pain during intravenousinjection. Timepoint: 1 minute after injection of propofol. Method of measurement: Fill questionare and visual scale.

Secondary

MeasureTime frame
Dermal side effects. Timepoint: From injection time untii ending of recovery time. Method of measurement: Fill questionare.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDR Seyedebrahim Sadeghi

Shiraz University of Medical Sciences

esadeghi@sums.ac.ir+98 71 4333 3278

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026